CDK4 and cancer: Further evidence of the importance of these pathways is the observation that loss of the CDKN2A locus encoding p16INK4A and p14ARF, which, respectively, inhibit CDK4/6 and activate the p53 tumor suppressor, are among the most commonly inactivated genes in cancer (including melanoma) [23,24].